Skip to main content
Erschienen in: Endocrine Pathology 1/2010

01.03.2010

Papillary Carcinoma Tall Cell Variant (TCV): A Review

verfasst von: Virginia A. LiVolsi

Erschienen in: Endocrine Pathology | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Tall cell variant of papillary thyroid carcinoma is an aggressive form of thyroid cancer with a significant mortality. This review describes the pathology of this variant, compares it to its pathologic mimics and discusses its clinical pathologic features. The literature on this tumor is reviewed. A brief discussion of molecular pathologic correlates is included.
Literatur
1.
Zurück zum Zitat Hawk WA, Hazard JB. The many appearances of papillary carcinoma of the thyroid. Clevel Clin Q. 43:207–15, 1976. Hawk WA, Hazard JB. The many appearances of papillary carcinoma of the thyroid. Clevel Clin Q. 43:207–15, 1976.
2.
Zurück zum Zitat Johnson TL, Lloyd RV, Thompson NW, Beierwaltes WH, Sisson JC. Prognostic implications of the tall cell variant of papillary thyroid carcinoma. Am J Surg Pathol. 12:22–7, 1988.PubMed Johnson TL, Lloyd RV, Thompson NW, Beierwaltes WH, Sisson JC. Prognostic implications of the tall cell variant of papillary thyroid carcinoma. Am J Surg Pathol. 12:22–7, 1988.PubMed
3.
Zurück zum Zitat DeLellis RA, Lloyd RV, Heitz PU, Eng C, editors. World Health Organization Classification of Tumours. Pathology and genetics of tumours of endocrine organs. Lyon: IARC; 2004. DeLellis RA, Lloyd RV, Heitz PU, Eng C, editors. World Health Organization Classification of Tumours. Pathology and genetics of tumours of endocrine organs. Lyon: IARC; 2004.
4.
Zurück zum Zitat Solomon A, Gupta PK, LiVolsi VA, Baloch ZW. Distinguishing tall cell variant of papillary thyroid carcinoma from usual variant of papillary thyroid carcinoma in cytologic specimens. Diagn Cytopathol. 27:143–8, 2002.CrossRefPubMed Solomon A, Gupta PK, LiVolsi VA, Baloch ZW. Distinguishing tall cell variant of papillary thyroid carcinoma from usual variant of papillary thyroid carcinoma in cytologic specimens. Diagn Cytopathol. 27:143–8, 2002.CrossRefPubMed
5.
Zurück zum Zitat Ghossein R, Leboeuf R, Patel KN, et al. Tall cell variant of papillary thyroid carcinoma without extra-thyroid extension: biologic behavior and clinical implications. Thyroid. 17:655–61, 2007.CrossRefPubMed Ghossein R, Leboeuf R, Patel KN, et al. Tall cell variant of papillary thyroid carcinoma without extra-thyroid extension: biologic behavior and clinical implications. Thyroid. 17:655–61, 2007.CrossRefPubMed
6.
Zurück zum Zitat Akslen LA, LiVolsi VA. Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma. Cancer. 88:1902–8, 2000.CrossRefPubMed Akslen LA, LiVolsi VA. Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma. Cancer. 88:1902–8, 2000.CrossRefPubMed
7.
Zurück zum Zitat Ostrowski ML, Merino MJ. Tall cell variant of papillary thyroid carcinoma: a reassessment and immunohistochemical study with comparison to the usual type of papillary carcinoma of the thyroid. Am J Surg Pathol. 20:964–74, 1996.CrossRefPubMed Ostrowski ML, Merino MJ. Tall cell variant of papillary thyroid carcinoma: a reassessment and immunohistochemical study with comparison to the usual type of papillary carcinoma of the thyroid. Am J Surg Pathol. 20:964–74, 1996.CrossRefPubMed
8.
Zurück zum Zitat Nishida T, Katayama S, Tsujimoto M, Nakamura J, Matsuda H. Clinicopathological significance of poorly differentiated thyroid carcinoma. Am J Surg Pathol. 23:205–11, 1999.CrossRefPubMed Nishida T, Katayama S, Tsujimoto M, Nakamura J, Matsuda H. Clinicopathological significance of poorly differentiated thyroid carcinoma. Am J Surg Pathol. 23:205–11, 1999.CrossRefPubMed
9.
Zurück zum Zitat Ghossein R, LiVolsi VA. Papillary thyroid carcinoma tall cell variant. Thyroid. 18:1179–81, 2008.CrossRefPubMed Ghossein R, LiVolsi VA. Papillary thyroid carcinoma tall cell variant. Thyroid. 18:1179–81, 2008.CrossRefPubMed
10.
Zurück zum Zitat Kakudo K, Bai Y, Katayama S, Hirokawa M, Ito Y, Miyauchi A, et al. Classification of follicular cell tumors of the thyroid gland: analysis involving Japanese patients from one institute. Pathol Int. 59:359–67, 2009.CrossRefPubMed Kakudo K, Bai Y, Katayama S, Hirokawa M, Ito Y, Miyauchi A, et al. Classification of follicular cell tumors of the thyroid gland: analysis involving Japanese patients from one institute. Pathol Int. 59:359–67, 2009.CrossRefPubMed
11.
Zurück zum Zitat Apel R, Asa S, LiVolsi VA. Papillary Hurthle cell carcinoma with lymphocytic stroma: “Warthin-like tumor” of the thyroid. Am J Surg Pathol. 19:810–4, 1995.PubMedCrossRef Apel R, Asa S, LiVolsi VA. Papillary Hurthle cell carcinoma with lymphocytic stroma: “Warthin-like tumor” of the thyroid. Am J Surg Pathol. 19:810–4, 1995.PubMedCrossRef
12.
Zurück zum Zitat Baloch ZW, LiVolsi VA. Fine-needle aspiration cytology of papillary Hurthle cell carcinoma with lymphocytic stroma “Warthin-like tumor” of the thyroid. Endocrine Pathol. 9:317–23, 1998.CrossRef Baloch ZW, LiVolsi VA. Fine-needle aspiration cytology of papillary Hurthle cell carcinoma with lymphocytic stroma “Warthin-like tumor” of the thyroid. Endocrine Pathol. 9:317–23, 1998.CrossRef
13.
Zurück zum Zitat Berho M, Suster S. The oncocytic variant of papillary carcinoma of the thyroid: a clinicopathologic study of 15 cases. Hum Pathol. 28:47–53, 1997.CrossRefPubMed Berho M, Suster S. The oncocytic variant of papillary carcinoma of the thyroid: a clinicopathologic study of 15 cases. Hum Pathol. 28:47–53, 1997.CrossRefPubMed
14.
Zurück zum Zitat Sobrinho-Simoes M, Maximo V, Castro IV, Fonseca E, Soares P, Garcia-Rostan G, et al. Hurthle (oncocytic cell tumors of thyroid: Etiopathogenesis, diagnosis and clinical significance. Int J Surg Pathol. 13:29–35, 2005.CrossRefPubMed Sobrinho-Simoes M, Maximo V, Castro IV, Fonseca E, Soares P, Garcia-Rostan G, et al. Hurthle (oncocytic cell tumors of thyroid: Etiopathogenesis, diagnosis and clinical significance. Int J Surg Pathol. 13:29–35, 2005.CrossRefPubMed
15.
Zurück zum Zitat Montone KT, Baloch ZW, LiVolsi VA. The thyroid Hurthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review. Arch Pathol Lab Med. 132:1241–50, 2008.PubMed Montone KT, Baloch ZW, LiVolsi VA. The thyroid Hurthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review. Arch Pathol Lab Med. 132:1241–50, 2008.PubMed
16.
Zurück zum Zitat Michels JJ, ScI MJ, Henry-Amar M, Bardet S. Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma. Hum Pathol. 38:212–9, 2007.CrossRefPubMed Michels JJ, ScI MJ, Henry-Amar M, Bardet S. Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma. Hum Pathol. 38:212–9, 2007.CrossRefPubMed
17.
Zurück zum Zitat Bronner MP, LiVolsi VA. Spindle cell squamous carcinoma of the thyroid: An unusual tumor associated with tall cell papillary cander. Mod Pathol. 4(5):637–643, 1991.PubMed Bronner MP, LiVolsi VA. Spindle cell squamous carcinoma of the thyroid: An unusual tumor associated with tall cell papillary cander. Mod Pathol. 4(5):637–643, 1991.PubMed
18.
Zurück zum Zitat Wreesmann VB, Sieczka EM, Socci ND, Hezel M, Belbin TJ, Childs G, et al. Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker. Cancer Res. 64:3780–9, 2004.CrossRefPubMed Wreesmann VB, Sieczka EM, Socci ND, Hezel M, Belbin TJ, Childs G, et al. Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker. Cancer Res. 64:3780–9, 2004.CrossRefPubMed
19.
Zurück zum Zitat Campo E, Merino MJ, Liotta L, Neumann R, Stetler-Stevenson W. Distribution of the 72-kd type IV collagenase in non neoplastic and neoplastic thyroid tissue. Hum Pathol. 23:1395–401, 1992.CrossRefPubMed Campo E, Merino MJ, Liotta L, Neumann R, Stetler-Stevenson W. Distribution of the 72-kd type IV collagenase in non neoplastic and neoplastic thyroid tissue. Hum Pathol. 23:1395–401, 1992.CrossRefPubMed
20.
Zurück zum Zitat Adeniran AJ, Zhu Z, Gandhi M, Steward D, Fidler JP, Giordano T, et al. Correlation between genetic alterations and microscopic features, clinical manifestations and prognostic characteristics of thyroid papillary carcinomas. Am J Surg Pathol. 30:216–22, 2006.CrossRefPubMed Adeniran AJ, Zhu Z, Gandhi M, Steward D, Fidler JP, Giordano T, et al. Correlation between genetic alterations and microscopic features, clinical manifestations and prognostic characteristics of thyroid papillary carcinomas. Am J Surg Pathol. 30:216–22, 2006.CrossRefPubMed
21.
Zurück zum Zitat Rivera M, Ghossein RA, Schoder H, Gomez D, Larson SM, Tuttle RM. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma. Cancer. 113:48–56, 2008.CrossRefPubMed Rivera M, Ghossein RA, Schoder H, Gomez D, Larson SM, Tuttle RM. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma. Cancer. 113:48–56, 2008.CrossRefPubMed
Metadaten
Titel
Papillary Carcinoma Tall Cell Variant (TCV): A Review
verfasst von
Virginia A. LiVolsi
Publikationsdatum
01.03.2010
Verlag
Humana Press Inc
Erschienen in
Endocrine Pathology / Ausgabe 1/2010
Print ISSN: 1046-3976
Elektronische ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-010-9106-y

Weitere Artikel der Ausgabe 1/2010

Endocrine Pathology 1/2010 Zur Ausgabe

EditorialNotes

Letter to the Editor

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Thiopental Originalie

Als Folge des Urteils des Bundesverfassungsgerichts zur Sterbehilfe im Jahr 2020 wurde in den Jahren 2021–2023 eine Reihe (n = 23) von assistierten Suiziden im Landesinstitut für gerichtliche und soziale Medizin Berlin mit jeweils identischen …

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …